Expression of CRYBG1, FGFR2 (fibroblast growth factor receptor 2), and RTN4IP1 (reticulon 4 interacting protein 1) was almost exclusive for MFM-223 across the BC cell lines panel (Figure 5A). Here, CRYBG1 is linked to breast cancer.